Anthem and Quest Diagnostics form strategic relationship

Multi-regional strategic initiatives agreement designed to improve efficiency in care delivery, reduce cost, and enhance experience for health care consumers and providers

17 Aug 2020
Sophie Ball
Publishing / Media

Industry news

Anthem Inc. and Quest Diagnostics have entered into a strategic relationship by collaborating on a variety of outcomes-based programs designed to create an improved health care experience for consumers and providers beginning August 1, 2020.

Anthem and Quest will work together to improve efficiency in care delivery and reduce overall costs by leveraging a broad range of tools and programs to drive operational improvements, create pricing transparency, and enhance health care consumer engagement and outcomes. The strategic relationship will focus on consumers in California, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, New Hampshire, New York, Ohio, Virginia, and Wisconsin.

"We are pleased to collaborate with Quest Diagnostics," said Paul Marchetti, Senior VP Health Care Management of Anthem, Inc. "Quest's tools and programs will provide critical insights to enable better health care for the consumers and communities we serve."

"We value our relationship with Anthem, and are excited about the framework of this agreement," said Jim Davis, Executive Vice President, General Diagnostics of Quest Diagnostics. "We look forward to demonstrating how our innovative solutions can help Anthem drive improvements in health care."

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>

Links

Tags

BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.